Hello, everyone, and nice to see you again. We hope your weekend was refreshing and enjoyable. Now, though, the time has come to resume that routine of meetings and deadlines, even if it is a short week here in the US. So please join us for an invigorating cup of stimulation. Meanwhile, here are some tidbits from around the world. Hope your day goes well and stay in touch...
FDA Inspects Numerous Plants In India (Economic Times)
Medicare Proposes Changes In Anemia Drug Usage (Reuters)
FDA Probes New Deaths Tied To Tainted Wipes (MSNBC)
Lilly Asks UK Judge To Reject Zyprexa Generics Case (Bloomberg News)
Ranbaxy Hires Lilly Exec As Pharma President (Economic Times)
Procter & Gamble Wins Round In Fixodent Cases (Cincinnati Enquirer)
J&J And Bayer's Xarelto Wins FDA OK For Hip Surgery (Bloomberg News)
Novartis Breast Cancer Drug Shows Positive Results (Reuters)
Choosing A Name For Prescription Drugs (The Boston Globe)
Demand For Toxicology Services Rises, But Not Pricing (Outsourcing Pharma)
Merck Stays Up Late To Develop Insomnia Pill (The Star-Ledger of NJ)
Painkillers Linked To Atrial Fibrillation In Study (Pharma Times)
Roche Drops Plan To Develop Chugai Diabetes Drug (Reuters)
Merck To Provide Study Protocols & Stat Analysis To Journals (Pharma Times)
EDITOR’S NOTE: Please check this post for updates throughout the morning
steaming coffee thx to dleggett on flickr
1 Comment
Drug names will remain convoluted until all possible permutations of "X" and "Z" have been exhausted.